The World Health Organisation says it is looking forward to reviewing clinical trials of a potential coronavirus vaccine developed in Russia.
Russia's vaccine, developed by the Gamaleya research institute and the defence ministry, is among the 28 in clinical evaluation but is listed by the WHO as only being in Phase 1.
“WHO is in touch with Russian scientists and authorities, and looks forward to reviewing details of the trials,” the United Nations health agency said in a statement.
“WHO welcomes all advances in Covid-19 vaccine research and development.”
